KO/PEP earnings spread: what changed and what didn’t after Coca-Cola’s beat

Coca-Cola beat Q3 estimates with adjusted EPS of $0.91 versus $0.88 and revenue of $13.4B versus $12.93B, while raising FY2026 EPS growth guidance to at least 11% from 9–10% and free cash flow guidance to at least $13.0B from about $12.4B. Organic revenue grew 7%, but North America volume was flat; KO shares fell 1.35% to $91.45 on Oct. 27, 2026. KO trades at 28.0x forward earnings versus PepsiCo’s 16.1x, leaving the relative-value case unresolved: KO’s stronger growth and estimate revisions support its premium, while valuation and performance gaps remain wide.

Analysis

The report weakens the case that KO’s premium is simply paying for growth that is about to fade; it does not establish that the premium is justified at its current level. The key market mechanism is estimate durability: if KO continues to deliver while PEP’s revisions fall, relative valuation can remain wide or widen despite KO’s muted one-day reaction. That reaction alone is not evidence the beat was fully priced in; broader market and positioning effects are unknown.

The quality of KO’s growth needs verification before extrapolating it. Management’s pricing contribution and the wire’s price/mix figure differ materially, and the reported North America volume flatness contrasts with stronger aggregate volume. Track unit volume, price/mix, FX and regional contribution in the next disclosures; a growth mix dependent on a narrow region or pricing would make KO’s premium more vulnerable. PEP’s negative revisions are also not a buy signal until their drivers and stabilization are confirmed.

Near term, avoid treating the valuation gap or fair-value estimates as catalysts. Over 1–3 months, relative estimate revisions and KO’s North America volume are the actionable tests; PEP’s next report is a later, tentative catalyst. Over 6–18 months, sustained growth and cash generation could support KO’s premium, while a volume slowdown could expose duration and multiple risk. The contrarian point: KO’s strong results may validate some premium, but they do not remove the asymmetric risk from a high-multiple stock after strong relative performance.

Key Decisions for Investors

• Do not initiate a full long PEP/short KO convergence pair solely on the valuation spread. KO’s improving fundamentals and PEP’s unresolved estimate cuts make the trade vulnerable to further divergence.
• Set an alert for a small, catalyst-led long PEP/short KO pair only if PEP estimate revisions stabilize and KO shows renewed weakness in North America volume or a material deterioration in price/mix. Define risk by closing the pair if PEP revisions resume falling or KO maintains volume and guidance.
• For existing KO longs, reassess exposure rather than automatically selling after the muted reaction. A sustained decline in North America unit volume or a downward guidance revision would be a more meaningful de-risking signal than valuation alone.
• Before acting, verify the pricing/price-mix discrepancy, KO regional and FX contributions, and the drivers behind PEP’s consensus EPS cuts. If these cannot be reconciled, keep the pair on watch rather than sizing a position.